Daewon Pharmaceutical Co., Ltd. (KRX:003220)
11,400
-140 (-1.21%)
At close: Feb 27, 2026
-21.11% (1Y)
| Market Cap | 244.98B -20.6% |
| Revenue (ttm) | 590.70B -0.5% |
| Net Income | -16.04B |
| EPS | -748.20 |
| Shares Out | 21.43M |
| PE Ratio | n/a |
| Forward PE | 32.20 |
| Dividend | 300.00 (2.62%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 31,423 |
| Average Volume | 45,807 |
| Open | 11,600 |
| Previous Close | 11,540 |
| Day's Range | 11,360 - 11,610 |
| 52-Week Range | 11,130 - 15,350 |
| Beta | 0.20 |
| RSI | 40.33 |
| Earnings Date | Mar 17, 2026 |